EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extracellular RNAs from Whole Urine to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia

Michele Stella, Giorgio Ivan Russo iD, Rosario Leonardi, Daniela Carcò, Giuseppe Gattuso iD, Luca Falzone iD, Carmen Ferrara, Angela Caponnetto, Rosalia Battaglia iD, Massimo Libra iD, Davide Barbagallo iD, Cinzia Di Pietro iD und 3 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251810079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Michele Stella und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Biotechnological Sciences, Section of Biology and Genetics "G. Sichel", University of Catania, 95123 Catania, Italy. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Prostatic Neoplasms, MicroRNAs, Biomarkers, Tumor. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE); Call H2020-MSCA-RISE-2020, EXCELLENT SCIENCE-Marie Skłodowska-Curie Actions-Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNAs, especially non-coding RNAs (ncRNAs), are crucial players in regulating cellular mechanisms due to their ability to interact with and regulate other molecules. Altered expression patterns of ncRNAs have been observed in prostate cancer (PCa), contributing to the disease’s initiation, progression, and treatment response. This study aimed to evaluate the ability of a specific set of RNAs, including long ncRNAs (lncRNAs), microRNAs (miRNAs), and mRNAs, to discriminate between PCa and the non-neoplastic condition benign prostatic hyperplasia (BPH). After selecting by literature mining the most relevant RNAs differentially expressed in biofluids from PCa patients, we evaluated their discriminatory power in samples of unfiltered urine from 50 PCa and 50 BPH patients using both real-time PCR and droplet digital PCR (ddPCR). Additionally, we also optimized a protocol for urine sample manipulation and RNA extraction. This two-way validation study allowed us to establish that miRNAs (i.e., miR-27b-3p, miR-574-3p, miR-30a-5p, and miR-125b-5p) are more efficient biomarkers for PCa compared to long RNAs (mRNAs and lncRNAs) (e.g., PCA3, PCAT18, and KLK3), as their dysregulation was consistently reported in the whole urine of patients with PCa compared to those with BPH in a statistically significant manner regardless of the quantification methodology performed. Moreover, a significant increase in diagnostic performance was observed when molecular signatures composed of different miRNAs were considered. Hence, the abovementioned circulating ncRNAs represent excellent potential non-invasive biomarkers in urine capable of effectively distinguishing individuals with PCa from those with BPH, potentially reducing cancer overdiagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic HyperplasiaProstatic NeoplasmsMicroRNAsBiomarkers, TumorHumansMaleAgedMiddle AgedDiagnosis, DifferentialRNA, Long NoncodingRNA, MessengerGene Expression Regulation, NeoplasticAged, 80 and over

Stichwörter der Autor:innen

BPHPCadiagnosisliquid biopsylncRNAmiRNAmolecular signaturencRNA

Substanzen

MicroRNAsBiomarkers, TumorRNA, Long NoncodingRNA, Messenger

Autor:innen und Institutionen

  • Department of Biomedical and Biotechnological Sciences, Section of Biology and Genetics "G. Sichel", University of Catania, 95123 Catania, Italy.
  • Department of Urology, Polyclinic Hospital, University of Catania, 95123 Catania, Italy.
  • Casa di Cura Musumeci GECAS, 95030 Gravina di Catania, Italy.
  • Department of Medicine and Surgery, University of Enna KORE, 94100 Enna, Italy.
  • Istituto Oncologico del Mediterraneo, 95029 Viagrande, Italy.
  • Department of Biomedical and Biotechnological Sciences, Oncologic, Clinical and General Pathology Section, University of Catania, 95123 Catania, Italy.

ORCID-Profile: Giorgio Ivan Russo, Giuseppe Gattuso, Luca Falzone, Rosalia Battaglia, Massimo Libra, Davide Barbagallo, Cinzia Di Pietro, Cristina Barbagallo, Marco Ragusa

Förderung

  • MSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE); Call H2020-MSCA-RISE-2020
  • EXCELLENT SCIENCE-Marie Skłodowska-Curie Actions-Project

Zitieren

APA

Stella, M., Russo, G. I., Leonardi, R., Carcò, D., Gattuso, G., Falzone, L., Ferrara, C., Caponnetto, A., Battaglia, R., Libra, M., Barbagallo, D., Di Pietro, C., Pernagallo, S., Barbagallo, C., & Ragusa, M. (2024). Extracellular RNAs from Whole Urine to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251810079

Vancouver

Stella M, Russo GI, Leonardi R, Carcò D, Gattuso G, Falzone L, et al. Extracellular RNAs from Whole Urine to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251810079

BibTeX
@article{Stella2024,
  author = {Stella, Michele and Russo, Giorgio Ivan and Leonardi, Rosario and Carcò, Daniela and Gattuso, Giuseppe and Falzone, Luca and Ferrara, Carmen and Caponnetto, Angela and Battaglia, Rosalia and Libra, Massimo and Barbagallo, Davide and Di Pietro, Cinzia and Pernagallo, Salvatore and Barbagallo, Cristina and Ragusa, Marco},
  title = {Extracellular RNAs from Whole Urine to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251810079}
}
Kostenlos starten →